PKU ANAMIX INFANT
NUTRICIA NUTRITION CLINIQUE CLINIQUE
Identification
- Active ingredient (INN)
- LAIT SANS PHENYLALANINE
- Internal code
- 14 L 130
- Country of Origin
- France
- Pharmaceutical form
- Powder for Infants (0-1 year)
- Prescription List
- OTC
- Packaging
- b/400g
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
Phenylalanine is an essential aromatic amino acid that is a precursor of melanin, dopamine, noradrenalin (norepinephrine), and thyroxine.
Indications
L-phenylalanine may be helpful in some with depression.
It may also be useful in the treatment of vitiligo.
There is some evidence that
L-phenylalanine may exacerbate tardive dyskinesia in some schizophrenic patients and in some who have used neuroleptic drugs.
Pharmacodynamics
Used by the brain to produce
Norepinephrine, a chemical that transmits signals between nerve cells and the brain; keeps you awake and alert; reduces hunger pains; functions as an antidepressant and helps improve memory.
Absorption
Absorbed from the small intestine by a sodium dependent active transport process.
Metabolism
L-phenylalanine that is not metabolized in the liver is distributed via the systemic circulation to the various tissues of the body, where it undergoes metabolic reactions similar to those that take place in the liver.
Adverse Effects
Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.
Toxicity
L-phenylalanine will exacerbate symptoms of phenylketonuria if used by phenylketonurics.
L-phenylalanine was reported to exacerbate tardive dyskinesia when used by some with schizophrenia.